Close Menu
  • Home
  • Tech&AI
    • Claude AI
    • Chatgpt
    • Gemini
    • Grok
  • News
    • Canada
    • United States
    • Australia
    • Europe
    • Asia
    • Africa
    • Politics
  • Classifieds Toronto
  • Service Canada
    • Immigration and citizenship
    • Renew your passport online in Canada
    • Service Canada
    • Service Ontario
      • Service Toronto
    • Service Alberta
      • Service Edmonton
      • Service Calgary
    • British Columbia
      • Victoria
      • Vancouver
    • Manitoba
      • Winnipeg
    • Quebec
      • Quebec City
      • Montreal
    • Newfoundland and Labrador
      • St. John’s
    • New Brunswick
      • Fredericton
      • Saint John
    • Nova Scotia
      • Halifax
    • Prince Edward Island
      • Charlottetown
    • Saskatchewan
      • Regina
      • Saskatoon
  • Education&Jobs
    • Universities in Canada
    • Toronto public schools
    • Free English lessons
    • Language Assessment and Referral Services
    • Toronto Public Library
    • Jobs in Canada
    • Job-Manpower
  • Home&Lifestyle
    • Buy or Rent a house
      • Realtor
      • Apartments for Rent in Toronto
    • Health
      • General hospital locations
      • Find a doctor or nurse
      • Health Canada
      • Toronto Health & Wellness
      • LifeLabs-Canada’s largest lab
    • Travel
      • Travel and tourism
      • Visit Toronto
      • Air Canada
    • Entertainment
    • Sports
  • Business
    • Finance
      • TD Bank
      • RBC Bank
      • CIBC Bank
      • BMO Bank
      • Scotia Bank
      • National Bank
    • Investing
      • Invest Canada
    • Companies
      • Ontario Business Registry
      • Trademarks
    • Stocks
      • Toronto stock Exchange
      • The New York Stock Exchange
      • Nasdaq: Stock Market
      • Yahoo Finances
    • Markets
      • Exhibition place
      • Metro Toronto Convention Centre
      • THE INTERNATIONAL CENTRE
      • Traders Forum Show
    • Crypto
    • Economy
  • Store
    • Make grocery shopping simple
    • Shopping Centres & Department Stores
    • COSTCO
    • Canadian Tire
    • Home Depot
    • Walmart
    • Foodbanks & Charities
  • Free TV
    • Free TV
    • Watch Free Movies Online with Plex
    • Korean TV
  • Free Games
    • Free Game1
    • Free game2
    • Europe
What's Hot

Mark Zuckerberg’s Meta AI Predicts the Flippening: How Does ADA Flip XRP?

November 20, 2026

Warsh wants Fed officials to talk less. Instead, they’re talking more

November 20, 2026

Experimental pancreatic cancer drug doubles survival time in trial

November 20, 2026
Facebook X (Twitter) Instagram
Friday, November 20
The Smart Times Toronto
Subscribe
  • Home
  • Tech&AI
    • Claude AI
    • Chatgpt
    • Gemini
    • Grok
  • News
    1. Canada
    2. United States
    3. Australia
    4. Europe
    5. Asia
    6. Africa
    7. Politics
    8. View All

    25 new prosecutors half to what is needed to make ‘meaningful change’ on Manitoba Crown workloads – Winnipeg

    November 20, 2026

    Stellantis meeting ‘challenging’ but ‘productive’, Premier Ford says

    November 20, 2026

    70 units ready in Saint John tiny home community as N.B. combats homelessness

    November 20, 2026

    Alberta tweaks carbon capture incentive program to allow grants during construction

    November 20, 2026

    Experimental pancreatic cancer drug doubles survival time in trial

    November 20, 2026

    Gavin Newsom called out by ‘The View’ for clearing death row without notice

    November 20, 2026

    Shopping With Friends: Celebrate National Espresso Day with Keurig’s new coffee and espresso maker

    November 20, 2026

    Trump asks Stephen Miller if he wants to run for president in 2028

    November 20, 2026

    Report calls for major change to Australia’s definition of terrorism

    November 20, 2026

    Aussie slips back as ace helps Korean to midway lead

    November 20, 2026

    Banged-up Bayern hang on for point against Cologne

    November 20, 2026

    2027 Tesla Model 3 price and specs

    November 20, 2026

    Kazakhstan’s Mangystau: Exploring surreal landscapes, underground mosques and desert camping

    November 20, 2026

    CNA Explains: What is Indonesia’s new asset forfeiture law and can wealth be seized without a criminal conviction?

    November 20, 2026

    The art of diplomacy: How China put symbolism and soft power on display at APEC

    November 20, 2026

    South Koreans sit key college exam mired in cheating scandal

    November 20, 2026

    Man who plotted to assassinate Sikh political dissident in NYC is sentenced to more than 19 years in prison

    November 20, 2026

    Bernie Moreno leads Senate tribute to Fiona the hippo after her death

    November 20, 2026

    House Ethics Committee aims to speed up sexual misconduct investigations

    November 20, 2026

    Marlon Jackson reveals 4-year battle with Stage 4 prostate cancer

    November 20, 2026

    Experimental pancreatic cancer drug doubles survival time in trial

    November 20, 2026

    Report calls for major change to Australia’s definition of terrorism

    November 20, 2026

    Kazakhstan’s Mangystau: Exploring surreal landscapes, underground mosques and desert camping

    November 20, 2026

    Iran war live: Saudi-led coalition downs Houthi missiles | News

    November 20, 2026
  • Classifieds Toronto
  • Service Canada
    • Immigration and citizenship
    • Renew your passport online in Canada
    • Service Canada
    • Service Ontario
      • Service Toronto
    • Service Alberta
      • Service Edmonton
      • Service Calgary
    • British Columbia
      • Victoria
      • Vancouver
    • Manitoba
      • Winnipeg
    • Quebec
      • Quebec City
      • Montreal
    • Newfoundland and Labrador
      • St. John’s
    • New Brunswick
      • Fredericton
      • Saint John
    • Nova Scotia
      • Halifax
    • Prince Edward Island
      • Charlottetown
    • Saskatchewan
      • Regina
      • Saskatoon
  • Education&Jobs
    • Universities in Canada
    • Toronto public schools
    • Free English lessons
    • Language Assessment and Referral Services
    • Toronto Public Library
    • Jobs in Canada
    • Job-Manpower
  • Home&Lifestyle
    • Buy or Rent a house
      • Realtor
      • Apartments for Rent in Toronto
    • Health
      • General hospital locations
      • Find a doctor or nurse
      • Health Canada
      • Toronto Health & Wellness
      • LifeLabs-Canada’s largest lab
    • Travel
      • Travel and tourism
      • Visit Toronto
      • Air Canada
    • Entertainment
    • Sports
  • Business
    • Finance
      • TD Bank
      • RBC Bank
      • CIBC Bank
      • BMO Bank
      • Scotia Bank
      • National Bank
    • Investing
      • Invest Canada
    • Companies
      • Ontario Business Registry
      • Trademarks
    • Stocks
      • Toronto stock Exchange
      • The New York Stock Exchange
      • Nasdaq: Stock Market
      • Yahoo Finances
    • Markets
      • Exhibition place
      • Metro Toronto Convention Centre
      • THE INTERNATIONAL CENTRE
      • Traders Forum Show
    • Crypto
    • Economy
  • Store
    • Make grocery shopping simple
    • Shopping Centres & Department Stores
    • COSTCO
    • Canadian Tire
    • Home Depot
    • Walmart
    • Foodbanks & Charities
  • Free TV
    • Free TV
    • Watch Free Movies Online with Plex
    • Korean TV
  • Free Games
    • Free Game1
    • Free game2
    • Europe
The Smart Times Toronto
Home»News»United States
United States

Experimental pancreatic cancer drug doubles survival time in trial

Press RoomBy Press RoomNovember 20, 2026No Comments4 Mins Read
Facebook Twitter Pinterest LinkedIn Reddit Telegram WhatsApp
Share
Facebook Twitter LinkedIn Pinterest Reddit Telegram WhatsApp

Pancreatic cancer breakthrough drug Rasonque doubles survival time in trial

Pancreatic cancer treatment receives a major boost as Dr. Monique Yohanan analyzes clinical trial results for Rasonque, a breakthrough drug from Revolution Medicines. The trial shows stage 4 patients achieved 13.2 months of median survival compared to just 6.7 months with standard chemotherapy. This development offers new hope against a disease with a historic three percent stage 4 survival rate.

NEWYou can now listen to Fox News articles!

Pairing an experimental pill with standard chemotherapy shrank tumors or halted growth in most patients with advanced pancreatic cancer, according to early clinical trial results presented Friday at a major international cancer conference.

The findings, shared at the EORTC-NCI-AACR Symposium in Barcelona, come from a phase 1/2 trial testing a daily oral medication called daraxonrasib, along with two standard intravenous chemotherapy drugs, gemcitabine and nab-paclitaxel.

The trial focused on 61 patients whose pancreatic cancer had already spread to other organs and who had not yet received treatment for their advanced disease.

PANCREATIC CANCER PATIENT BEN SASSE SEES ‘MASSIVE’ TUMOR REDUCTION WITH EXPERIMENTAL NEW DRUG

Pancreatic cancer is notoriously difficult to treat, because more than half of patients are diagnosed after the disease has already spread, research shows.

In major clinical trials for metastatic pancreatic cancer, chemotherapy alone shrinks tumors in about 23% to 42% of patients, but the disease typically begins growing again after five to six months, and most patients survive between eight and 11 months.

man-taking-pill

Combining an experimental daily pill called daraxonrasib with standard chemotherapy shrank tumors or stopped cancer growth in 90.2% of patients with untreated, advanced pancreatic cancer. (iStock)

According to National Cancer Institute data, only about 3% of patients with distant-stage disease live five years past diagnosis.

In the new study, which tracked patients for a median follow-up of 18 months, tumors shrank in 60.7% of cases, including 8.2% where they disappeared entirely on scans. Overall, the combination stopped tumor growth in 90.2% of participants.

FDA APPROVES ONCE-DAILY PILL FOR DEADLY CANCER AFTER PATIENTS’ SURVIVAL RATES NEARLY DOUBLE

Patients went a median of 12.8 months before their cancer worsened, almost double the timeframe typically seen with standard chemotherapy, and 76.6% were still alive at the one-year mark, the study found.

“We are now seeing not only substantial tumor shrinkages, including complete responses, but also durable disease control, with median progression-free survival exceeding one year,” said study lead Dr. Wungki Park, a gastrointestinal medical oncologist at Memorial Sloan Kettering Cancer Center in New York, in a press release.

woman sits at home while receiving chemo

Most side effects, including rash, diarrhea, fatigue and low blood cell counts, were manageable with standard care, and only 5% of patients stopped treatment due to daraxonrasib. (iStock)

More than 90% of pancreatic cancers are driven by a faulty gene called RAS, which allows tumors to keep growing. Daraxonrasib is designed to turn off that growth signal, something scientists long thought was impossible to fix with medication.

Dr. Elena Garralda, chair of the symposium and co-director of the clinical research program at the Vall d’Hebron Institute of Oncology in Spain, who was not involved in the research, said the results show that RAS-targeted drugs can be combined with existing treatments at the start of treatment to potentially achieve longer-lasting benefits.

CLICK HERE FOR MORE HEALTH STORIES

Side effects included rash, diarrhea, fatigue and low blood cell counts linked to chemotherapy, most of which were manageable with standard care.

Only 5% of patients stopped treatment because of side effects tied to daraxonrasib.

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

Researchers emphasized that the findings carry some limitations.

Because this was an early-phase, single-group study involving 61 people, all participants received the experimental combination. Without a direct comparison group of patients receiving standard chemotherapy alone, doctors cannot yet confirm how much better the new regimen performs or whether it definitively extends overall survival.

medical scan of human pancreas

Researchers are now running a larger, randomized phase 3 trial to directly compare the new treatment against standard chemotherapy. (iStock)

The findings also apply strictly to metastatic pancreatic cancer, even though RAS mutations drive several other cancers, including certain lung, colorectal and gynecological cancers. Separate studies would be needed to test whether the combination works in those diseases.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

The trial was funded by Revolution Medicines, the California-based developer of daraxonrasib.

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

To determine whether these early findings translate into a durable survival benefit, researchers have launched a larger, randomized phase 3 trial, called RASolute-303, which directly compares daraxonrasib — both on its own and combined with chemotherapy — against standard chemotherapy alone.

Khloe Quill is a lifestyle writer with Fox News Digital. She and the lifestyle team cover a range of story topics including food and drink, travel, and health. 

Share. Facebook Twitter Pinterest LinkedIn Reddit Telegram WhatsApp
Press Room
  • Website

Keep Reading

Gavin Newsom called out by ‘The View’ for clearing death row without notice

Shopping With Friends: Celebrate National Espresso Day with Keurig’s new coffee and espresso maker

Trump asks Stephen Miller if he wants to run for president in 2028

Iran mocks Treasury Secretary Scott Bessent for relocating to military base

New York City mayor Zohran Mamdani shows up to City Hall event on crutches thanks to soccer injury

James Carville calls out Pramila Jayapal over Hakeem Jeffries remark

Add A Comment
Leave A Reply Cancel Reply

THJ MAILBOX SERVICES
GOLDBAY TELECOM INC.
Facebook X (Twitter) Pinterest Vimeo WhatsApp TikTok Instagram

News

  • World News
  • United States
  • Canada
  • Europe
  • Australia
  • Asia
  • Africa

Business

  • Stocks
  • Economy
  • Finance
  • Investing
  • Markets
  • Companies
  • Crypto

SITE LINKS

  • Newsletter
  • Community
  • Work with us
  • Press Room
  • Media
  • Cookie Policy
  • About Us

Subscribe to Updates

Get the latest politics, business, sports, lifestyle, and many more news directly to your inbox.

© 2026 The Smart Times Toronto. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Press Release
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.